Kentucky House Bill 469 Seeks to Block Any Use of Gene Therapy (Including mRNA) for Infectious Diseases

House Bill 469 in Kentucky seeks to prohibit the administration of any human gene therapy product for infectious disease indications in Kentucky, regardless of whether the treatment is labeled as a vaccine, immunization, or another term. The bill includes a temporary ban until July 1, 2035, unless extended by the General Assembly, and provides exemptions for gene therapy used to treat cancer or genetic disorders.

Goal of the Bill